De Novo device
BEAR® (Bridge-Enhanced ACL Restoration) Implant
Miach Orthopaedics, Inc. · Resorbable Implant For Anterior Cruciate Ligament (Acl) Repair (QNI, Class II) · First FDA decision Dec 16, 2020, newest Jan 13, 2026Ligament, tendon and cartilage injuries
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
De Novo pathway
Device trials
33
Naming "BEAR"
MAUDE reports
116
Brand "BEAR", since 2015
PubMed studies
33,759
Mentioning "BEAR"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing BEAR® (Bridge-Enhanced ACL Restoration) Implant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K251214 · Decided Jan 13, 2026 · 270 days after receipt
Device type: Resorbable Implant For Anterior Cruciate Ligament (Acl) Repair (QNI) · Orthopedic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "BEAR", any status and sponsor, newest update first.
- ABVN Phase 1 - Vagal ManeuversCompleted
Indiana UniversityAcademic, hospital or other
NCT07881276 · 82 participants · Start Aug 19, 2019 · Primary completion Nov 15, 2022
Device: Multi-Electrode Array (MEA) Recording · For: Healthy Subjects
Sites: Indianapolis, Indiana
32 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "BEAR", and for the whole product code for context.
This brand
116 reports: 41 malfunction, 74 injury, 0 death
Whole product code QNI
43 reports: 33 malfunction, 10 injury, 0 death
Newest reports for this brand
3020652-2026-00010 · Received Oct 8, 2026 · Event dated Sep 10, 2026
Device type: Resorbable Implant For Anterior Cruciate Ligament (Acl) Repair (QNI)
Device problem as coded: Material Too Soft/Flexible
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- BEAR Implant. Model Number: 1000.Open, Classified
Z-1220-2026 · Started Dec 31, 2025 · Posted by FDA Jan 29, 2026
Reason given: Incorrect expiration date on label that extends beyond the product's documented/approved shelf life. With an incorrect expiration date, the UDI will also be incorrect.
Cause as FDA categorized it: Process control · Device type: Resorbable Implant For Anterior Cruciate Ligament (Acl) Repair (QNI)
1 more recall records with a free account
Published research
The most relevant PubMed records for "BEAR"[tiab]. The summary above synthesizes these.
- Xanthogranulomatous pyelonephritis: "Bear's paw sign".
Tonkaz G, Tonkaz M, Erkal Tonkaz D, et al. · Med Clin (Barc) · 2024Case Reports
- Bear's paw sign in xanthogranulomatous pyelonephritis.
Mon HC, Ou YL, Fan HT, et al. · QJM · 2025
- Polar bear paw pad surface roughness and its relevance to contact mechanics on snow.
Orndorf N, Garner AM, Dhinojwala A · J R Soc Interface · 2022Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
- Papa Bear's Journal Club Survival Guide.
Tigges S · J Am Coll Radiol · 2023
- Xanthogranulomatous Pyelonephritis: "Bear's Paw Sign".
Lee JH, Kim SS, Kim DS · J Belg Soc Radiol · 2019Case Reports
- Sri Lankan Sloth Bear (Melursus ursinus inornatus) Attacks on Humans.
Thalgaspitiya SPB, Siriwardana A, Chenthuran V, et al. · Wilderness Environ Med · 2022
- BEAR: A Novel Virtual Screening Method Based on Large-Scale Bioactivity Data.
Kwon Y, Park S, Lee J, et al. · J Chem Inf Model · 2023Research Support, Non-U.S. Gov't
- [Xanthogranulomatous pyelonephritis : bear paw sign].
Partoune M, Danthine D · Rev Med Liege · 2024Case Reports
- Bear mauling: a descriptive review.
Dieter RA, Dieter DL, Dieter RA, et al. · Int J Circumpolar Health · 2001Review
- Physicians of the Bear-Flag Republic.
Bengtsson BS · J Med Biogr · 2016Biography, Historical Article
- Asiatic Black Bear-Human Conflict: A Case Study from Guthichaur Rural Municipality, Jumla, Nepal.
Rawal AK, Timilsina S, Gautam S, et al. · Animals (Basel) · 2024
- Patients with bear-associated injuries may vary between countries.
Aoki K, Watanabe A, Kakisaka Y, et al. · Injury · 2023Letter
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.